Pharmacokinetics of vitexin in rats after intravenous and oral administration

被引:12
|
作者
Wang, Yunjiao [2 ]
Han, Chunhui [1 ]
Leng, Aijing [1 ]
Zhang, Wenjie [2 ]
Xue, Hefei [2 ]
Chen, Yinghui [2 ]
Yin, Jingjing [2 ]
Lu, Dongrui [2 ]
Ying, Xixiang [2 ]
机构
[1] Dalian Med Univ, Affiliated Hosp 1, Dalian 116011, Peoples R China
[2] Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian 116600, Peoples R China
来源
AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY | 2012年 / 6卷 / 31期
关键词
Bioavailability; high-performance liquid chromatography (HPLC); pharmacokinetics; rat plasma; vitexin; POLYPHENOLS;
D O I
10.5897/AJPP12.534
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Vitexin was isolated from the leaves of Crataegus pinnatifida Bge. var major, and its pharmacokinetics and bioavailability were carried out via validated high-performance liquid chromatography (HPLC) method using hesperidin as internal standard in healthy rats after intravenous and oral administration at a dose of 10 mg/kg and 30 mg/kg, respectively. The pharmacokinetic parameters were calculated by both compartmental and non-compartmental approach. When intravenous administration was used, the elimination half-life (t(1/2 beta)), the mean residence (MRT0 -> t), the total body clearance (CL) were 46.01 +/- 0.810 min, 26.23 +/- 1.51 min and 0.031 +/- 0.035 L/kg.min. When oral administration was used, the t(max) and C-max were 15.82 +/- 0.172 min and 0.51 +/- 0.015 mu g/ml, the MRT0 -> t and CL were 60.41 +/- 5.41 min and 0.71 +/- 0.056 L/kg.min. The result showed that vitexin was rapidly eliminated and presented a low absolute bioavailability (F), 4.91 +/- 0.761%.
引用
收藏
页码:2368 / 2373
页数:6
相关论文
共 50 条
  • [21] PHARMACOKINETICS OF PENTOBARBITAL AFTER INTRAVENOUS AND ORAL ADMINISTRATION
    SMITH, RB
    DITTERT, LW
    GRIFFEN, WO
    DOLUISIO, JT
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (01): : 5 - 16
  • [22] PHARMACOKINETICS OF MEPIXANOX AFTER ORAL AND INTRAVENOUS ADMINISTRATION
    GROSSI, G
    STURANI, C
    BATTISTONI, R
    LIPPI, A
    BOSCHI, S
    STROCCHI, E
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1985, 38 (01): : 141 - 146
  • [23] Preclinical Pharmacokinetics and Bioavailability of Oxypeucedanin in Rats after Single Intravenous and Oral Administration
    Zheng, Ming-Cong
    Tang, Wen-Ting
    Yu, Lu-Lu
    Qian, Xun-Jia
    Ren, Jie
    Li, Jie-Jia
    Rong, Wei-Wei
    Li, Jun-Xu
    Zhu, Qing
    MOLECULES, 2022, 27 (11):
  • [24] Effects of Hydrocortisone on the Pharmacokinetics of Loratadine after Oral and Intravenous Loratadine Administration to Rats
    Choi, Jun Shik
    Choi, In
    Burm, Jin Pil
    BIOMOLECULES & THERAPEUTICS, 2009, 17 (02) : 205 - 210
  • [25] PHARMACOKINETICS OF ALPHA-DIHYDROERGOCRYPTINE IN RATS AFTER INTRAVENOUS AND ORAL-ADMINISTRATION
    GROGNET, JM
    ISTIN, M
    ZANOTTI, A
    MAILLAND, F
    COPPI, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1991, 41-2 (07): : 689 - 691
  • [26] Dose-independent pharmacokinetics of torasemide after intravenous and oral administration to rats
    Lee, DY
    Kim, JY
    Kim, YC
    Kwon, JW
    Kim, WB
    Lee, MG
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2005, 26 (05) : 173 - 182
  • [27] Effects of prednisolone on the pharmacokinetics of loratadine after oral and intravenous administration of loratadine in rats
    Cheng Li
    Minhee Kim
    Jun-Shik Choi
    Archives of Pharmacal Research, 2010, 33 : 1395 - 1400
  • [28] Effects of Amlodipine on the Pharmacokinetics of Warfarin after Oral and Intravenous Administration of Warfarin in Rats
    Choi, Dong-Hyun
    Piao, Yong-Ji
    Choi, Eun-Joo
    Choi, Jun-Shik
    Burm, Jin-Pil
    BIOMOLECULES & THERAPEUTICS, 2011, 19 (04) : 493 - 497
  • [29] Effects of Prednisolone on the Pharmacokinetics of Loratadine after Oral and Intravenous Administration of Loratadine in Rats
    Li, Cheng
    Kim, Minhee
    Choi, Jun-Shik
    ARCHIVES OF PHARMACAL RESEARCH, 2010, 33 (09) : 1395 - 1400
  • [30] Pharmacokinetics of oltipraz after intravenous and oral administration in rats with dehydration for 72 hours
    Bae, SK
    Lee, SJ
    Kim, JW
    Kim, YH
    Kim, SG
    Lee, MG
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2005, 26 (02) : 77 - 83